A previous study reported that ARPC2 was closely associated with the stage, nodal metastasis, and overall survival in breast cancer and that the TGF-β/EMT pathway is involved in ARPC2-mediated carcinogenesis (Cheng et al., 2019). This evidence concerns the gene ARPC2 and breast carcinoma.